EUVIMEDEUVIMED entdecken
Open Access

Creatine Kinase as a Potential Diagnostic Biomarker for Distinguishing Placenta Accreta Spectrum and Placenta Previa: A Prospective Pilot Study

Lulu Wang, Tianjiao Liu, Liwen Yang, Xinyu Xiao, Jiaxin Chen, Limin Wang

Journal of Obstetrics and Gynaecology Research · 2026

DOI: 10.1111/jog.70472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Lulu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Placenta Accreta, Placenta Previa, Creatine Kinase. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the 2025 First Batch of Chengdu Municipal Key Research and Development Projects, Yingcai Scheme of Chengdu Women's and Children's Central Hospital, Japan-China Sasakawa Fellowship Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Placenta previa (PP) and placenta accreta spectrum (PAS) are major causes of severe obstetric hemorrhage, yet in some scenarios, antenatal discrimination and risk stratification remain challenging with imaging alone. An inexpensive, widely available adjunct biomarker such as maternal serum creatine kinase (CK) may help differentiate PP from PAS, reflect imaging‐based placental severity, and identify women at increased risk of intraoperative massive hemorrhage.

Methods

This pilot prospective cohort study enrolled women with singleton pregnancies managed at a tertiary center between January 2025 and January 2026 with suspected PP or PAS. PP and PAS were confirmed by intraoperative inspection and postoperative histopathology. Serum CK was measured using third‐trimester blood samples. Ultrasound and MRI placental scores were calculated using predefined scoring systems. Spearman correlation assessed associations between CK and imaging scores. Multivariable logistic regression explored risk factors for intraoperative massive hemorrhage.

Results

Thirty‐one participants were included (PP, n = 22; PAS, n = 9). Late‐gestation CK levels were significantly higher in PAS than PP (78.28 ± 30.01 vs. 38.07 ± 17.86 U/L; p = 0.041). PAS had higher ultrasound and MRI placental scores than PP (both p < 0.001). CK was moderately positively correlated with the ultrasound score ( ρ = 0.484, p = 0.003) and MRI score ( ρ = 0.401, p = 0.026). In multivariable analyses, higher CK, more prior cesarean deliveries, and higher ultrasound and MRI scores were associated with increased odds of intraoperative massive hemorrhage.

Conclusion

Late‐gestation maternal serum CK was elevated in PAS versus PP, correlated with ultrasound‐ and MRI‐based placental scores, and was associated with massive hemorrhage risk, suggesting CK as a potential adjunct biomarker for PAS.

Trial registration

ChiCTR2100054068, December 8, 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Placenta AccretaPlacenta PreviaCreatine KinaseHumansFemalePregnancyPilot ProjectsAdultBiomarkersProspective StudiesDiagnosis, DifferentialMagnetic Resonance ImagingUltrasonography, Prenatal

Stichwörter der Autor:innen

creatine kinasemagnetic resonance imagingplacenta accreta spectrumplacenta previaultrasonography

Substanzen

BiomarkersCreatine Kinase

Autor:innen und Institutionen

  • Department of Obstetrics, Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan, China.
  • Department of Gynecology, Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan, China.
  • Department of Ultrasonography, Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan, China.

Förderung

  • the 2025 First Batch of Chengdu Municipal Key Research and Development Projects
  • Yingcai Scheme of Chengdu Women's and Children's Central Hospital
  • Japan-China Sasakawa Fellowship Program

Zitieren

APA

Wang, L., Liu, T., Yang, L., Xiao, X., Chen, J., & Wang, L. (2026). Creatine Kinase as a Potential Diagnostic Biomarker for Distinguishing Placenta Accreta Spectrum and Placenta Previa: A Prospective Pilot Study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70472

Vancouver

Wang L, Liu T, Yang L, Xiao X, Chen J, Wang L. Creatine Kinase as a Potential Diagnostic Biomarker for Distinguishing Placenta Accreta Spectrum and Placenta Previa: A Prospective Pilot Study. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70472

BibTeX
@article{Wang2026,
  author = {Wang, Lulu and Liu, Tianjiao and Yang, Liwen and Xiao, Xinyu and Chen, Jiaxin and Wang, Limin},
  title = {Creatine Kinase as a Potential Diagnostic Biomarker for Distinguishing Placenta Accreta Spectrum and Placenta Previa: A Prospective Pilot Study},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  doi = {10.1111/jog.70472}
}
Kostenlos starten →